We use cookies to understand how you use our site and to improve your experience.
This includes personalizing content and advertising.
By pressing "Accept All" or closing out of this banner, you consent to the use of all cookies and similar technologies and the sharing of information they collect with third parties.
You can reject marketing cookies by pressing "Deny Optional," but we still use essential, performance, and functional cookies.
In addition, whether you "Accept All," Deny Optional," click the X or otherwise continue to use the site, you accept our Privacy Policy and Terms of Service, revised from time to time.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
The Chemours Company (CC - Free Report) recorded a loss of $27 million or 18 cents per share in third-quarter 2024. This compares to a profit of $12 million or 8 cents in the year-ago quarter. Barring one-time items, earnings came in at 40 cents. It topped the Zacks Consensus Estimate of 32 cents.
Find the latest EPS estimates and surprises on Zacks Earnings Calendar.
The company reported net sales of $1,501 million in the third quarter, up nearly 1% year over year. It beat the Zacks Consensus Estimate of $1,425.2 million. A 5% rise in volumes was partly offset by a 3% decline in price and a modest 1% currency headwind. CC saw record third-quarter sales in its Thermal & Specialized Solutions division, driven by the growth in Opteon refrigerants.
The Chemours Company Price, Consensus and EPS Surprise
The Thermal & Specialized Solutions division recorded sales of $460 million for the quarter, reflecting a 6% rise compared to the previous year. This was above the consensus estimate of $437.9 million. This upside was driven by an 8% increase in volumes, partly offset by a 2% decline in prices.
In the Titanium Technologies segment, revenues fell 2% year-over-year to $679 million in the reported quarter. This was above the consensus estimate of $626.3 million. The downside was mainly due to a 2% decline in pricing, partly masked by a 1% increase in volumes.
Sales in the Advanced Performance Materials unit were $348 million, up 1% year over year. It beat the consensus estimate of $345.8 million. The uptick was driven by a 9% increase in volumes, partly offset by a 7% decline in pricing and a 1% currency headwind.
Chemours’ Financials
Chemours ended the quarter with cash and cash equivalents of $596 million, down around 1% sequentially. Long-term debt was $3,988 million, up roughly 1% from the prior quarter.
Cash provided by operating activities for the reported quarter was $139 million compared with $131 million in the year-ago quarter.
CC’s Q4 Outlook
The company expects consolidated net sales to decline in the mid to high-single digits sequentially in the fourth quarter. Consolidated adjusted EBITDA is forecast to be down in the high teens to low 20% range compared with third-quarter 2024 results.
CC forecasts a sequential low-teens sales decline in the Thermal & Specialized Solutions unit in the fourth quarter due to refrigerant seasonality. It expects the segment to maintain double-digit year-over-year growth in Opteon. Adjusted EBITDA for the segment is forecast to decline in the low-20% range sequentially due to refrigerant seasonality
The company expects a mid-to-high-single-digit sequential sales decline in Titanium Technologies in the fourth quarter on seasonality-driven lower volumes. Adjusted EBITDA for the unit is forecast to decline between mid-to-high teens.
For Advanced Performance Materials, CC expects a low-single-digit sales decline in the fourth quarter due to macro weakness in advanced materials end markets, partly offset by gains in performance solutions. Adjusted EBITDA for the segment is forecast to be flat sequentially, supported by the favorable contribution from performance solutions sales and cost-reduction actions.
CC Stock’s Price Performance
Chemours’ shares are down 19.9% in the past year compared with the Zacks Chemicals Diversified industry’s 8.3% rise.
IAMGOLD is scheduled to release third-quarter results on Nov. 7. The Zacks Consensus Estimate for IAG’s third-quarter earnings is pegged at 11 cents. IAG beat the consensus estimate in each of the last four quarters with the average surprise being 200%. Its shares have shot up roughly 120% in the past year.
Barrick Gold is slated to release third-quarter results on Nov. 7. The consensus estimate for GOLD’s third-quarter earnings is pegged at 33 cents. The company's shares have rallied roughly 20% in the past year.
Sandstorm Gold is scheduled to release third-quarter results on Nov. 7. The Zacks Consensus Estimate for SAND’s third-quarter earnings is pegged at 3 cents. SAND has rallied around 36% in the past year.
See More Zacks Research for These Tickers
Normally $25 each - click below to receive one report FREE:
Image: Bigstock
Chemours' Earnings and Revenues Surpass Estimates in Q3
Key Takeaways
The Chemours Company (CC - Free Report) recorded a loss of $27 million or 18 cents per share in third-quarter 2024. This compares to a profit of $12 million or 8 cents in the year-ago quarter. Barring one-time items, earnings came in at 40 cents. It topped the Zacks Consensus Estimate of 32 cents.
Find the latest EPS estimates and surprises on Zacks Earnings Calendar.
The company reported net sales of $1,501 million in the third quarter, up nearly 1% year over year. It beat the Zacks Consensus Estimate of $1,425.2 million. A 5% rise in volumes was partly offset by a 3% decline in price and a modest 1% currency headwind. CC saw record third-quarter sales in its Thermal & Specialized Solutions division, driven by the growth in Opteon refrigerants.
The Chemours Company Price, Consensus and EPS Surprise
The Chemours Company price-consensus-eps-surprise-chart | The Chemours Company Quote
CC’s Segment Highlights
The Thermal & Specialized Solutions division recorded sales of $460 million for the quarter, reflecting a 6% rise compared to the previous year. This was above the consensus estimate of $437.9 million. This upside was driven by an 8% increase in volumes, partly offset by a 2% decline in prices.
In the Titanium Technologies segment, revenues fell 2% year-over-year to $679 million in the reported quarter. This was above the consensus estimate of $626.3 million. The downside was mainly due to a 2% decline in pricing, partly masked by a 1% increase in volumes.
Sales in the Advanced Performance Materials unit were $348 million, up 1% year over year. It beat the consensus estimate of $345.8 million. The uptick was driven by a 9% increase in volumes, partly offset by a 7% decline in pricing and a 1% currency headwind.
Chemours’ Financials
Chemours ended the quarter with cash and cash equivalents of $596 million, down around 1% sequentially. Long-term debt was $3,988 million, up roughly 1% from the prior quarter.
Cash provided by operating activities for the reported quarter was $139 million compared with $131 million in the year-ago quarter.
CC’s Q4 Outlook
The company expects consolidated net sales to decline in the mid to high-single digits sequentially in the fourth quarter. Consolidated adjusted EBITDA is forecast to be down in the high teens to low 20% range compared with third-quarter 2024 results.
CC forecasts a sequential low-teens sales decline in the Thermal & Specialized Solutions unit in the fourth quarter due to refrigerant seasonality. It expects the segment to maintain double-digit year-over-year growth in Opteon. Adjusted EBITDA for the segment is forecast to decline in the low-20% range sequentially due to refrigerant seasonality
The company expects a mid-to-high-single-digit sequential sales decline in Titanium Technologies in the fourth quarter on seasonality-driven lower volumes. Adjusted EBITDA for the unit is forecast to decline between mid-to-high teens.
For Advanced Performance Materials, CC expects a low-single-digit sales decline in the fourth quarter due to macro weakness in advanced materials end markets, partly offset by gains in performance solutions. Adjusted EBITDA for the segment is forecast to be flat sequentially, supported by the favorable contribution from performance solutions sales and cost-reduction actions.
CC Stock’s Price Performance
Chemours’ shares are down 19.9% in the past year compared with the Zacks Chemicals Diversified industry’s 8.3% rise.
CC’s Zacks Rank & Other Key Picks
CC currently carries a Zacks Rank #4 (Sell).
Better-ranked stocks in the Basic Materials space are IAMGOLD Corporation (IAG - Free Report) , Barrick Gold Corporation (GOLD - Free Report) and Sandstorm Gold Ltd. (SAND - Free Report) . While IAMGOLD carries a Zacks Rank #1 (Strong Buy), both Barrick Gold and Sandstorm Gold carry a Zacks Rank #2 (Buy). You can see the complete list of today’s Zacks #1 Rank stocks here.
IAMGOLD is scheduled to release third-quarter results on Nov. 7. The Zacks Consensus Estimate for IAG’s third-quarter earnings is pegged at 11 cents. IAG beat the consensus estimate in each of the last four quarters with the average surprise being 200%. Its shares have shot up roughly 120% in the past year.
Barrick Gold is slated to release third-quarter results on Nov. 7. The consensus estimate for GOLD’s third-quarter earnings is pegged at 33 cents. The company's shares have rallied roughly 20% in the past year.
Sandstorm Gold is scheduled to release third-quarter results on Nov. 7. The Zacks Consensus Estimate for SAND’s third-quarter earnings is pegged at 3 cents. SAND has rallied around 36% in the past year.